Schawk (SGK) Enters New $125M unsecured Revolver
Get Alerts SGK Hot Sheet
Join SI Premium – FREE
Schawk, Inc. (NYSE: SGK), has refinanced its $90 million senior secured revolving credit facility through a new $125 million unsecured senior revolving credit facility. In addition, the company has separately entered into a new unsecured $75 million private shelf facility.
The new $125 million unsecured facility, which matures in January 2017, lowers the company's current interest rate (at closing) by approximately 125 basis points for revolver-based borrowings. The facility bears interest at a rate of LIBOR plus a margin that varies with the company's leverage ratio. At closing, that margin is 175 basis points.
The outstanding amount borrowed under the former $90 million revolving credit facility, which was due to expire in July 2012, was approximately $69 million at December 31, 2011. The unutilized portion of the new $125 million facility will be used for general corporate purposes, such as working capital and capital expenditures, and, to the extent opportunities arise, acquisitions and investments.
The new $125 million unsecured facility, which matures in January 2017, lowers the company's current interest rate (at closing) by approximately 125 basis points for revolver-based borrowings. The facility bears interest at a rate of LIBOR plus a margin that varies with the company's leverage ratio. At closing, that margin is 175 basis points.
The outstanding amount borrowed under the former $90 million revolving credit facility, which was due to expire in July 2012, was approximately $69 million at December 31, 2011. The unutilized portion of the new $125 million facility will be used for general corporate purposes, such as working capital and capital expenditures, and, to the extent opportunities arise, acquisitions and investments.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hanmi Pharm licenses obesity drug to Genentech in $2.3B deal
- CoVolt Power files for proposed IPO
- Alzamend Neuro (ALZN) files for 98.4M share offering by selling stockholders
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share